Longeveron Inc.

NASDAQ:LGVN

2.05 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Revenue 0.4680.5480.0630.150.2170.2790.1210.2650.4660.370.2090.2320.4890.3761.181.8650.8761.7081.843
Cost of Revenue 0.3530.4720.3010.0960.1240.2030.1750.1730.3060.070.140.0680.2810.2270.6511.4920.7640.8961.236
Gross Profit 0.1150.076-0.2380.0540.0930.076-0.0540.0920.160.30.0690.1640.2080.1490.5290.3730.1120.8120.607
Gross Profit Ratio 0.2460.139-3.7780.360.4290.272-0.4460.3470.3430.8110.330.7070.4250.3960.4480.20.1280.4750.329
Reseach & Development Expenses 1.4931.9661.921.8432.2872.783.2632.961.721.4271.7332.0481.961.351.1520.5850.6420.2890.343
General & Administrative Expenses 2.1222.23.0793.0923.3751.8551.6372.0742.4271.982.282.9963.2572.2010.7020.7020.6490.6860.734
Selling & Marketing Expenses 000.2030.280.1430.1570.2850.2450.2340.2870.0880.0250.0530.0560.0590.0440.0470.050.005
SG&A 2.1222.23.2823.3723.5182.0121.9222.3192.6612.2672.3683.0213.312.2570.7610.7460.6960.7360.739
Other Expenses 0.0870.032-0.5580.0550.080.0690.683-0.057-0.005-0.116-0.0360.0510.0540.0470.030.0240.010-0
Operating Expenses 3.6154.1665.2025.2155.8054.7925.1855.2794.3813.6944.1015.0695.273.6071.9121.3311.3381.0251.081
Operating Income -3.5-4.09-5.44-5.161-5.712-4.716-5.239-5.187-4.221-3.394-4.032-4.905-5.062-3.458-1.383-0.958-1.226-0.213-0.474
Operating Income Ratio -7.479-7.464-86.349-34.407-26.323-16.903-43.298-19.574-9.058-9.173-19.292-21.142-10.352-9.197-1.172-0.514-1.4-0.125-0.257
Total Other Income Expenses Net 0.0870.032-0.588-0.7430.080.0690.683-0.057-1.403-0.116-0.0360.0510.0540.3470.030.0240.010-0
Income Before Tax -3.413-4.058-6.028-5.904-5.632-4.647-4.556-5.244-5.624-3.51-4.069-4.855-5.01-3.111-1.356-0.938-1.216-0.213-0.474
Income Before Tax Ratio -7.293-7.405-95.683-39.36-25.954-16.656-37.653-19.789-12.069-9.486-19.469-20.927-10.245-8.274-1.149-0.503-1.388-0.125-0.257
Income Tax Expense 00.210.301-0.2320.118-0.069-0.7840.0571.4030.116-0.0060.0520.056-0.30.0330.0280.0100
Net Income -3.413-4.058-6.028-5.904-5.632-4.578-3.772-5.301-7.027-3.626-4.069-4.855-5.01-3.111-1.356-0.938-1.216-0.213-0.474
Net Income Ratio -7.293-7.405-95.683-39.36-25.954-16.409-31.174-20.004-15.079-9.8-19.469-20.927-10.245-8.274-1.149-0.503-1.388-0.125-0.257
EPS -0.52-1.61-2.55-2.79-2.67-2.18-1.79-0.25-0.34-0.17-0.2-0.25-0.26-0.18-0.08-0.059-0.076-0.013-0.027
EPS Diluted -0.52-1.61-2.55-2.79-2.67-2.18-1.79-0.25-0.34-0.17-0.2-0.25-0.26-0.18-0.078-0.059-0.076-0.013-0.027
EBITDA -3.271-3.837-5.204-5.161-5.472-4.716-4.556-5.004-3.997-3.206-3.836-4.618-4.757-3.563-1.157-0.736-1.019-0.018-0.279
EBITDA Ratio -6.989-7.002-82.603-34.407-25.217-16.903-37.653-18.883-8.577-8.665-18.354-19.905-9.728-9.476-0.981-0.395-1.163-0.011-0.151